Oral contraceptives forged new FDA ground

Fifty years after its approval, the birth control pill has led to profound changes in the FDA itself. Many of the steps that underlie modern drug approvals--extensive clinical trials, routine referrals to panels of outside experts, continuing assessments of a medicine's safety, and direct communications between the FDA and patients--were pioneered to deal with evolving concerns about the pill's safety. Report

Suggested Articles

After years of having first-line liver cancer market to itself, Bayer’s Nexavar is getting major competition from Roche's Tecentriq.

Most of the recent enthusiasm around AbbVie’s new drugs has centered on Skyrizi and Rinvoq, but elagolix wants a piece of the spotlight, too.

During David Loew's tenure, Sanofi Pasteur bought Protein Sciences, whose recombinant technology is being applied to a COVID-19 vaccine.